The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 CA036727
National Institutes of Health
Grant: T32 CA009476
National Institutes of Health
Grant: U54 GM115458
National Institutes of Health
Grant: R25 CA221777
National Institutes of Health
Grant: P30 GM127200
National Institutes of Health
Grant: 5T32CA009476-11
CANCER BIOLOGY TRAINING PROGRAM
National Institutes of Health
Grant: 1F32GM013039-01
MOLECULAR ANALYSIS OF THE YEAST HEAT SHOCK TRANSCRIPTION
National Institutes of Health
Grant: 3U54GM115458-07S2
Great Plains IDeA-CTR
National Institutes of Health
Grant: 5R25CA221777-04
Ignite-Engage-Sustain: a comprehensive approach to motivate, involve, educate, and mentor Native American students and their communities in cancer prevention, treatment, and research
National Institutes of Health
Grant: 5P30GM127200-04
Nebraska Center for Nanomedicine
National Institutes of Health
Grant: 5P30CA036727-23
CORE--Confocal Microscopy
UNMC Graduate Studies Office Fellowship Program
State of Nebraska
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals